Clinical Trial Update: C-Reactive Protein (CRP) in Obese Diabetic Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of a study evaluating C-reactive protein in obese women with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED